Skip to main content
. 2022 Feb 7;10(2):e003465. doi: 10.1136/jitc-2021-003465

Figure 7.

Figure 7

Integrin αvβ6 inhibits T-cell immune response in the majority of patients with colorectal cancer. (A) Kaplan-Meier curves of disease free survival by ITGB6 gene expression status. Minimum p value approach was used to obtain an optimal discrimination of the total patient group into two subgroups with different disease-free survival depending on the level of ITGB6. Differences in survival were compared by logrank test. ITGB6 low: n=109, ITGB6 high: n=234. (B) Relative ITGB6 mRNA expression of all 521 patients in the TCGA-COAD dataset. (C) Relative mRNA expression in the 50 patients with lowest ITGB6 expression compared with the remaining 471 patients of the TCGA-COAD dataset. Means and SDs are shown. Mann-Whitney test was used to calculate statistical significance. *P<0.05, **p<0.01, ***p<0.001, ****p<0.0001.